Please login to the form below

Not currently logged in
Email:
Password:

Extavia

This page shows the latest Extavia news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

to Novartis’ Extavia which had been the only recommended drug after a first cost appraisal.

Latest news

  • Novartis’ Extavia evades NICE restrictions on MS drugs Novartis’ Extavia evades NICE restrictions on MS drugs

    Multiple sclerosis patients in England and Wales look set to have just one interferon therapy option after draft NICE guidance backed routine funding for Novartis’ Extavia and rejected other drugs. ... The MS Society said the proposals won’t affect

  • Biogen Idec sues for patent infringement

    Rebif generated global sales of $2.1bn in 2009, and Extavia achieved $20m in the first quarter. ... Novartis received approval last year to sell Extavia and currently pays royalties to Bayer.

  • FDA approves Extavia for MS

    Extavia received EU approval in May 2008 to treat early and relapsing forms of MS. ... Extavia is reportedly the "first in a new planned portfolio" of MS medicines for Novartis.

  • Novartis gets MS drug approval

    Novartis has announced that the European Commission has granted approval for its new multiple sclerosis (MS) treatment, Extavia, and has said it intends to continue broadening its product range in this ... Extavia is the same as the MS treatment Betaferon

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....